| Michael J Alazard, MD | |
|
2350 W Horizon Ridge Pkwy, Henderson, NV 89052-5075 | |
| (702) 564-8556 | |
| (702) 564-4485 |
| Full Name | Michael J Alazard |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 2350 W Horizon Ridge Pkwy, Henderson, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851359491 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 9421 (Nevada) | Secondary |
| 208000000X | Pediatrics | 9421 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael J Alazard, MD 2350 W Horizon Ridge Pkwy, Henderson, NV 89052-5075 Ph: (702) 564-8556 | Michael J Alazard, MD 2350 W Horizon Ridge Pkwy, Henderson, NV 89052-5075 Ph: (702) 564-8556 |
News Archive
University of Washington researchers are developing the first smartphone app that is capable of objectively detecting concussion and other traumatic brain injuries in the field: on the sidelines of a sports game, on a battlefield or in the home of an elderly person prone to falls.
BioAtla LLC, a biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, today announced that it has entered into a license and option agreement with Pfizer Inc. to advance the development and commercialization of a new class of antibody therapeutics based on BioAtla's CAB platform and utilizing Pfizer's proprietary antibody drug conjugate (ADC) payloads.
Chronic obstructive pulmonary disease (COPD) affects a large number of subjects worldwide and is characterised by a progressively rising epidemiological, clinical and socio-economic impact. The objectives of treatment are to decrease the burden of the disease through relief of symptoms, improvement of exercise tolerance, and prevention and treatment of exacerbations.
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application for pertuzumab and granted Priority Review.
A simple balance test may predict cognitive decline in Alzheimer's Disease, according to a study published in the March 2009 issue of the Journal of Alzheimer's Disease.
› Verified 4 days ago
Emily K Peterson, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 10001 S Eastern Ave Ste 101, Henderson, NV 89052 Phone: 702-616-5870 | |
Dr. Jagannath Surpure, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1600 W Sunset Rd Ste A, Henderson, NV 89014 Phone: 702-898-6400 Fax: 702-898-7032 | |
Laura F Teisch, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2350 West Horizon Ridge Parkway, Henderson, NV 89052 Phone: 702-564-8556 Fax: 702-564-4485 | |
Tatiana Stephanoff, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6301 Mountain Vista St Ste 205, Henderson, NV 89014 Phone: 702-614-5437 Fax: 702-990-9922 | |
Rosemary Y Hyun, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2350 W Horizon Ridge Pkwy, Henderson, NV 89052 Phone: 702-564-8556 Fax: 702-564-4485 | |
Dr. Stella Maris Delgado-almenario, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2510 Wigwam Pkwy, Suite 103, Henderson, NV 89074 Phone: 702-558-3551 Fax: 702-361-0983 | |
Natasa Mihic, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 871 Coronado Center Dr Ste 141, Henderson, NV 89052 Phone: 702-566-2400 Fax: 702-433-2477 |